Australia markets closed

MedX Health Corp (MDX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.0600+0.0100 (+20.00%)
At close: 03:50PM EST
Currency in CAD

Valuation measures4

Market cap (intra-day) 15.72M
Enterprise value 21.36M
Trailing P/E N/A
Forward P/E 23.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)20.11
Price/book (mrq)N/A
Enterprise value/revenue 35.45
Enterprise value/EBITDA -6.59

Trading information

Stock price history

Beta (5Y monthly) 1.19
52-week change 350.00%
S&P500 52-week change 315.38%
52-week high 30.0900
52-week low 30.0300
50-day moving average 30.0636
200-day moving average 30.0696

Share statistics

Avg vol (3-month) 341.38k
Avg vol (10-day) 321.92k
Shares outstanding 5261.96M
Implied shares outstanding 6202.66M
Float 8183.32M
% held by insiders 19.06%
% held by institutions 10.02%
Shares short (14 Nov 2023) 46.49k
Short ratio (14 Nov 2023) 40.12
Short % of float (14 Nov 2023) 4N/A
Short % of shares outstanding (14 Nov 2023) 40.00%
Shares short (prior month 14 Sept 2023) 469.88k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-750.06%

Management effectiveness

Return on assets (ttm)-277.82%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)602.57k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)23.40%
Gross profit (ttm)N/A
EBITDA -3.41M
Net income avi to common (ttm)-5.36M
Diluted EPS (ttm)-0.0300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)186.15k
Total cash per share (mrq)0
Total debt (mrq)5.83M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.09
Book value per share (mrq)-0.04

Cash flow statement

Operating cash flow (ttm)-3.77M
Levered free cash flow (ttm)-3.18M